Compare Interactive Brokers Group Inc. Class A Common Stock (IBKR) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Interactive Brokers Group Inc. Class A Common Stock vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? Interactive Brokers Group Inc. Class A Common Stock trades at $87.14 (market cap $39.18B), while Iovance Biotherapeutics Inc. Common Stock trades at $13.43 (market cap $6.04B). The key difference: Interactive Brokers Group Inc. Class A Common Stock is far larger — about 6.5× Iovance Biotherapeutics Inc. Common Stock's market cap, and Interactive Brokers Group Inc. Class A Common Stock pays a 0.4% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Interactive Brokers Group Inc. Class A Common Stock for 0 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| IBKR | IOVA | |
|---|---|---|
Market Cap | $39.18B | $6.04B |
Volume | 2,996,599 | 14,805,993 |
Sector | Financials | Health |
52-Week High | $98.19 | $14.82 |
52-Week Low | $61.05 | $1.81 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $31.48B | $5.97B |
Dividend Yield | 0.4% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Interactive Brokers Group Inc. Class A Common Stock
Interactive Brokers operates an electronic brokerage platform for trading stocks, options, futures, currencies, and other assets. It also provides clearing and custody services.
Read more on IBKR →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
